U.S. Corporations Face Reckoning Over Prescription Opioids, CEOs Keep Cashing In
Companies that sold or distributed opioid medications face huge legal, financial and public relations peril. Critics say shareholders, not CEOs, will pay the price.
leia mais em NPR
No comments:
Post a Comment